International Clinical Trial: Assessing the impact of short-course Zopiclone on Continuous Positive Away Pressure (CPAP) effectiveness for people with Obstructive Sleep Apnoea (OSA) who wake easily

Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001009404) titled 'Assessing the impact of short-course Zopiclone on Continuous Positive Away Pressure (CPAP) effectiveness for people with Obstructive Sleep Apnoea (OSA) who wake easily' on Sept. 11.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Flinders University

Condition: Obstructive Sleep Apnoea Insomnia Obstructive Sleep Apnoea Insomnia Respiratory - Sleep apnoea Mental Health - Other mental health disorders

Intervention: Zopiclone (7.5mg) each night for 4-weeks (30 days) in conjunction with CPAP initiation.

Timing of dosage: To be taken with...